Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

67053 1513184208HCLSReviewBulgariaDecember2017.pdf
Energy Boardroom

Type your email in the box below to read this content NOW:

Interview

Assena Stoimenova – Member of the Management Board, EMA; Executive Director, BDA

Assena Stoimenova, member of the management board of the European Medicines Agency (EMA) and executive director of the Bulgarian Drug Agency (BDA), explains the Agency’s evolution under her tenure as well as her commitment to ensuring that the BDA remains predictable, transparent and fair, being fully focused on safeguarding patients and society’s interests.

Ms. Stoimenova, you were appointed as Executive Director of the Bulgarian Drug Agency (BDA) in July 2014. How would you assess the evolution of the institution under your tenure?

For the last three years, we have made significant progresses in establishing Bulgaria as an active partner in marketing authorizations for medicinal products in the EU as well as GMP inspections in third countries.

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: